Second primary tumor after immune checkpoint inhibitor therapy: A case report.

MLA

Miao, Kang, et al. “Second Primary Tumor after Immune Checkpoint Inhibitor Therapy: A Case Report.” Thoracic Cancer, vol. 13, no. 7, Apr. 2022, pp. 1076–78. EBSCOhost, https://doi.org/10.1111/1759-7714.14327.

APA

Miao, K., Yu, S., Ni, J., Zhang, X., & Zhang, L. (2022). Second primary tumor after immune checkpoint inhibitor therapy: A case report. Thoracic Cancer, 13(7), 1076–1078. https://doi.org/10.1111/1759-7714.14327

Chicago

Miao, Kang, Shuangni Yu, Jun Ni, Xiaotong Zhang, and Li Zhang. 2022. “Second Primary Tumor after Immune Checkpoint Inhibitor Therapy: A Case Report.” Thoracic Cancer 13 (7): 1076–78. doi:10.1111/1759-7714.14327.